Yu Wan

2.0k citations
58 papers · 1.6k indexed · h-index 19

Impact in

Papers in

Yu Wan

54 papers receiving 1.6k citations

Peers

Yu Wan
Comparison fields: 5 of 107
  • Behavioral Neuroscience 103
  • Reproductive Medicine 187
  • Endocrinology, Diabetes and Metabolism 360
  • Cancer Research 190
  • Biomaterials 140
Replace Roberto Frairia with:
Roberto Frairia Italy
Anna Markowska Poland
Éric Rhéaume Canada
Verónica López United States
Suzanne Bertera United States
H. Mizunuma Japan
Ioulia Chatzistamou United States
Narender Kumar United States
Pablo Damián‐Matsumura Mexico
Yu Wan relative to Roberto Frairia Italy Roberto Frairia's profile →
Citations per field
00.5×3.4×
Roberto Frairia · 1×
Citations per year

Countries citing papers authored by Yu Wan

Since Specialization
Citations

This map shows the geographic impact of Yu Wan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yu Wan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yu Wan more than expected).

Fields of papers citing papers by Yu Wan

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yu Wan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yu Wan. The network helps show where Yu Wan may publish in the future.

Co-authors

The 25 scholars most cited alongside Yu Wan, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Yu Wan Line = papers co-authored together Yu Wan links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown
#Work
1 20250
2 20252
3 20251
4 20250
5 20240
6 202412
7 20241
8 202411
9 202313
10 20234
11 202313
12 202213
13 201527
14 201537
15 201427
16 201179
17 201011
18 200811
19 200425
20 199714

About Yu Wan

Yu Wan is a scholar working on Endocrinology, Diabetes and Metabolism, Cancer Research, Applied Microbiology and Biotechnology, Molecular Biology and Genetics, having authored 58 papers that have together received 1.6k indexed citations. Recurring topics across this work include RNA Interference and Gene Delivery (15 papers), Growth Hormone and Insulin-like Growth Factors (11 papers), Nanoplatforms for cancer theranostics (11 papers), Advanced biosensing and bioanalysis techniques (11 papers), Virus-based gene therapy research (9 papers), Nanoparticle-Based Drug Delivery (5 papers), Cancer, Hypoxia, and Metabolism (5 papers) and MicroRNA in disease regulation (4 papers). The work is most often cited by research in Behavioral Neuroscience (103 citations), Reproductive Medicine (187 citations), Endocrinology, Diabetes and Metabolism (360 citations), Cancer Research (190 citations) and Biomaterials (140 citations). Yu Wan has collaborated with scholars based in China, Australia and United States. Frequent co-authors include Gang Yang, Michael J. Waters, Johannes D. Veldhuis, Frederik J. Steyn, Allan E. Herbison, Jenny Clarkson, Chen Chen, Chuanshu Huang, Yonghui Yu and István Tóth. Their work appears in journals such as Acta Biomaterialia, Neurosignals, Nanomedicine, Molecular Pharmaceutics and Endocrinology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026